Page 901 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 901

Hippel-Lindau syndrome  257–258                                                                                               Index 887
     infant hemangiomas and  257–258
                                                            Humoral rejection, acute  137f, 138
Hirschsprung disease                                        Hunter syndrome. See Mucopolysaccharidosis (MPS)
     as intestinal obstruction  573–574                     Huntington disease (HD)
     morphology of  574b, 574f
     pathogenesis of  574b                                       morphology of  840b, 840f
                                                                 neurodegenerative diseases and  840
Histamine  46                                                    pathogenesis of  840b
Histiocytic neoplasm  449                                   Hurler syndrome. See Mucopolysaccharidosis (MPS)
Histiocytoma, benign fibrous  794                           Hyaline membrane disease. See Respiratory distress syndrome
Histoplasmosis                                                   (RDS)
                                                            Hyaluronan  64
     clinical features of  499–500                          Hydatid cyst  314
     epidemiology of  499–500                               Hydatidiform mole
     morphology of  499b, 500f                                   as gestational trophoblastic disease  701–702, 702t
     as pulmonary infection  499–500                             morphology of  702b, 702f
HIV. See Human immunodeficiency virus (HIV)                      summary for  703b
HLA. See Human leukocyte antigen (HLA)                      Hydrocephalus  812–813, 813f
Hodgkin lymphoma                                                 summary for  814b
     classification of  440–442                             Hydronephrosis
     as lymphoid neoplasm  440–442                               clinical course of  546–547
     morphology of  440b–441b, 440f                              morphology of  546b, 546f
     pathogenesis of  441b–442b                                  pathogenesis of  546b
     staging and clinical features of  442, 442t                 and urinary outflow obstruction  545–547
     summary for  444                                       Hydrops, nonimmune  255–257
Hodgkin lymphoma, lymphocyte-predominance  441,             Hydrops fetalis  254, 255f, 256b, 257
     441f                                                   Hydrostatic pressure  77, 77f
Hodgkin lymphoma, nodular sclerosis  440, 440f–441f         Hyperadrenalism. See Adrenocortical hyperfunction
Holoprosencephaly  247–248                                  Hyperaldosteronism
Homologous recombination, DNA repair and  197                    and adrenocortical hyperfunction  755–756
Homozygous  183                                                  clinical features of  756
Host immune response  321–322                                    morphology of  755b–756b
Human anti-globulin test (Coombs test)  256–257             Hypercholesterolemia  336–337
Human immunodeficiency virus (HIV). See also Acquired       Hypercholesterolemia, familial
     immunodeficiency syndrome (AIDS)                            gene encoding mutations and  222–223
     B cells and other lymphocytes in  149                       pathogenesis of  222b–223b
     dendric cells and  149                                      summary for  223b
     etiology/pathogenesis of AIDS and  144–149             Hypercoagulability  87–88, 87t
     heroin and  286                                        Hypercortisolism. See also Cushing syndrome
     life cycle of  145–146, 146f                                and adrenocortical hyperfunction  752–755, 753f
     mechanisms of T cell depletion in  147–148, 148f, 150       summary for  755b
     monocytes/macrophages in  148–149                      Hyperemia  75
     morphology of  152b                                         morphology of  75b–76b, 76f
     natural history/clinical course for  150–153, 150f     Hyperglycemia  835
                                                            Hyperhomocysteinemia  337–338
          acute phase of  150                               Hyper-IgM syndrome  141, 143
          chronic phase of  150                             Hyperlipidemia  336–337
          clinical features of  151–153, 151t               Hyperparathyroidism
          crises phase of  150–151                               acquired bone disease as  771
          neoplasms and  151–152                                 clinical features of  737–738, 737t
          opportunistic infections and  151                      morphology of  736b–737b, 736f–737f, 772b, 772f
     nervous system infections and  828, 832                     and parathyroid glands  735–738
          morphology of  827f, 828b                              pathogenesis of  736b
     pathogenesis of CNS involvement for  149                    secondary hyperparathyroidism and  738
     progression of infection and  146–147, 147f, 147t           summary for  738b
     pulmonary infections in  504                           Hyperparathyroidism, secondary
     structure of  144–145, 145f                                 clinical features of  738
     summary for  149b–150b                                      introduction to  738
Human leukocyte antigen (HLA)                                    morphology of  738b
     adoptive immunity and  102, 124t                            summary for  738
     genetic factors of SLE and  126                        Hyperpituitarism
     graft survival and  138                                     and the pituitary gland  717–720
     GVHD and  139
Human leukocyte antigen allele, polymorphisms and  234                (See also Pituitary adenoma)
Human papillomavirus (HPV)  202                                  summary for  719b
Human papillomavirus (HPV) infection                        Hyperplasia
     morphology of  678b                                         as adaptive response  1–2
     sexually transmitted disease and  678                       hypertrophy and  3
     summary for  678b–679b                                      stress and  4
Humoral immunity  100, 108f                                      summary for  5b
     as antitumor effector mechanism  206–207                    vitamin A and  298
   896   897   898   899   900   901   902   903   904   905   906